ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Bioassay Backlog Reports show Increasing Number Of Equivocal Results; Is The Program A Failure?

September 2, 1977

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

ONF Seeks Applications For Grants In Fatigue

March 31, 1995

Bristol-Myers Cancer Scientist Award Nominations To Close March 1

February 24, 1978

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985